When people search for "peptides for weight loss," the query almost always points to one class of molecules: GLP-1 receptor agonists. Both Ozempic and Mounjaro belong to it. Here is a plain breakdown of how they work, how the four compounds we stock for research differ, and why purity matters more than price.
Note. This is educational material about research-use compounds. It is not medical advice and not instructions for human use.
what GLP-1 is and why it affects weight
GLP-1, or glucagon-like peptide-1, is released by the gut after a meal and acts as an incretin hormone. It has a few effects. It slows gastric emptying, so fullness lasts longer. It signals satiety to the brain, so appetite drops. And it boosts insulin release exactly when blood glucose is high.
Native GLP-1 survives only minutes in the blood. Synthetic analogues are engineered to last far longer, from daily to weekly dosing in research protocols. That stability is what separates the modern compounds from the early attempts.
four compounds and how they differ
All four act on appetite and metabolism, but through different receptors. Here is a short comparison.
| Compound | Receptors | Pharmacy brand | In short |
|---|---|---|---|
| semaglutide | GLP-1 | Ozempic, Wegovy | single receptor, the largest data set |
| tirzepatide | GIP + GLP-1 | Mounjaro, Zepbound | dual action, stronger effect on weight in studies |
| retatrutide | GIP + GLP-1 + glucagon | none, still in development | triple agonist, in trials |
| cagrilintide | amylin | none on its own | amylin analogue, studied mostly paired with semaglutide |
On raw effect on body weight, studies usually rank them retatrutide, then tirzepatide, then semaglutide. But the most long-term safety data sits with semaglutide, because it came first. Cagrilintide is the odd one out: it acts on the amylin receptor rather than GLP-1, and it is studied mainly in combination with semaglutide.
research alternatives to the pharmacy brands
A pharmacy drug and a research compound carry the same active molecule. The difference is packaging and status. A pharmacy brand is a registered medicine in a prescription pen. A research compound is a pure substance in a vial for lab work, with no prescription labelling. We covered each pair in more detail:
- Ozempic and semaglutide: how the brand and the molecule relate, and what "analogues" means
- Mounjaro (tirzepatide) vs Ozempic: what the research shows
why purity beats price
The peptide market is full of grey-market sellers. Relabelled powder, under-dosed vials, Telegram channels that vanish the moment you pay. When you cannot see what is actually in the vial, a low price means nothing.
Our approach is different. Every batch ships with a lab Certificate of Analysis (COA) confirming purity above 99%. You check any lot yourself: enter the batch number at /verify and you open the same COA we hold. No need to take our word for it, you can read the numbers.
Here is what to check before buying research peptides:
- Is there a COA for your specific batch, not a "generic" certificate?
- Is purity given as a percentage with the method (HPLC)?
- Can you verify the lot number on the site, not just in a photo?
- Does the stated dose match the mass in the vial?
So our position is simple: verifiable purity beats a low price. Start with the monograph for the compound you want above, check the COA, then decide.
